https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: a nested case control study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15679 Wed 11 Apr 2018 17:12:34 AEST ]]> Vitamin D levels are associated with expression of SLE, but not flare frequency https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18250 1:80) and frequency of self-reported flares (SRF) in participants with clinical autoimmunity (SLE). 25(OH)D levels of 121 females were quantified and compared. The cohort consisted of 80 ACR defined SLE patients and 41 age and sex matched controls. Association analysis of log2 (25(OH)D) levels and ANA 80 positivity was undertaken via two-sample t-tests and regression models. Significant differences were found for 25(OH)D levels (mean: control 74nmol/L (29.5ng/ml); SLE 58nmol/L (23.1ng/ml), P = 0.04), 25(OH)D deficiency (P = 0.02). Regression models indicate that, for a twofold rise in 25(OH)D level, the odds ratio (OR) for ANA-positivity drops to 36% of the baseline OR. No link was found between SRF-days and 25(OH)D levels. Our results support links between vitamin D deficiency and expression of serological autoimmunity and clinical autoimmunity (SLE). However, no demonstrable association between 25(OH)D and SRF was confirmed, suggesting independent influences of other flare-inducing factors. Results indicate that SLE patients have high risk of 25(OH)D deficiency and therefore supplementation with regular monitoring should be considered as part of patient management.]]> Wed 11 Apr 2018 16:45:13 AEST ]]> Thyroid disease in chronic hepatitis C Infection and interferon-α based therapy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:13683 Wed 11 Apr 2018 13:31:00 AEST ]]> The natural history of interferon-α induced thyroiditis in chronic hepatitis c patients: a long term study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15682 Wed 11 Apr 2018 11:23:52 AEST ]]> Continuous inappropriate use of serum tumour markers (letter) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:567 Thu 25 Jul 2013 09:10:39 AEST ]]> Life-threatening milk-alkali syndrome resulting from antacid ingestion during pregnancy (letter) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:518 Thu 25 Jul 2013 09:10:26 AEST ]]> Treatment of type B insulin resistance with immunoglobulin: novel use of an old therapy (letter) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:7019 Sat 24 Mar 2018 08:38:04 AEDT ]]> Development of thyroid diseases in the treatment of chronic hepatitis C with alpha-interferon may be a good prognosticator in achieving a sustained virological response: a meta-analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:8319 Sat 24 Mar 2018 08:36:54 AEDT ]]> A novel missense LIPA gene mutation, N98S, in a patient with cholesteryl ester storage disease https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:4785 Sat 24 Mar 2018 07:20:44 AEDT ]]> Hepatitis C infection and thyrotoxic periodic paralysis: a novel use of an old drug https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:4769 Sat 24 Mar 2018 07:20:41 AEDT ]]> Histopathologic findings of autoimmunity in thyroid, pituitary, and adrenal diseases in chronic hepatitis C postmortem cases https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:11187 Mon 08 Apr 2019 11:10:00 AEST ]]> Thyroid disease in chronic hepatitis C infection treated with combination interferon-α and ribavirin: management strategies and future perspective https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19984 Mon 08 Apr 2019 11:09:34 AEST ]]>